Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 836390, 12 pages
http://dx.doi.org/10.1155/2015/836390
Research Article

Matrix Metalloproteinase 9 Secreted by Hypoxia Cardiac Fibroblasts Triggers Cardiac Stem Cell Migration In Vitro

1School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
2Periodical Newsroom, Tianjin University of Traditional Chinese Medicine, Tianjin, China

Received 26 September 2014; Revised 25 January 2015; Accepted 25 January 2015

Academic Editor: Lucio Barile

Copyright © 2015 Qing Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. U. Hong and R. Bolli, “Cardiac stem cell therapy for cardiac repair,” Current Treatment Options in Cardiovascular Medicine, vol. 16, no. 7, article 324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. V. di Felice, A. de Luca, M. L. Colorito et al., “Cardiac stem cell research: an elephant in the room?” Anatomical Record, vol. 292, no. 3, pp. 449–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. X. Liang and W. D. Phillips, “Migration of resident cardiac stem cells in myocardial infarction,” The Anatomical Record, vol. 296, no. 2, pp. 184–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Wang, X. Zhao, C. Kuang et al., “Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway,” PLoS ONE, vol. 7, no. 9, Article ID e43922, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Cerrada, A. Ruiz-Saurí, R. Carrero et al., “Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair,” Stem Cells and Development, vol. 22, no. 3, pp. 501–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Sanada, J. Kim, A. Czarna et al., “C-kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy,” Circulation Research, vol. 114, no. 1, pp. 41–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Ma, L. E. de Castro Brás, H. Toba et al., “Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling,” Pflugers Archiv European Journal of Physiology, vol. 466, no. 6, pp. 1113–1127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Souders, S. L. K. Bowers, and T. A. Baudino, “Cardiac fibroblast: the renaissance cell,” Circulation Research, vol. 105, no. 12, pp. 1164–1176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Porter and N. A. Turner, “Cardiac fibroblasts: at the heart of myocardial remodeling,” Pharmacology & Therapeutics, vol. 123, no. 2, pp. 255–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Abrial, C. C. Da Silva, B. Pillot et al., “Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 68, pp. 56–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Urbanek, D. Torella, F. Sheikh et al., “Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692–8697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Garbern and R. T. Lee, “Cardiac stem cell therapy and the promise of heart regeneration,” Cell Stem Cell, vol. 12, no. 6, pp. 689–698, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Bearzi, M. Rota, T. Hosoda et al., “Human cardiac stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068–14073, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Linke, P. Müller, D. Nurzynska et al., “Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966–8971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Oikonomopoulos, K.-I. Sereti, and R. Liao, “Resident cardiac stem/progenitor cells for cardiac regeneration,” Drug Discovery Today: Therapeutic Strategies, vol. 5, no. 4, pp. 193–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Dawn, A. B. Stein, K. Urbanek et al., “Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766–3771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. X. L. Tang, G. Rokosh, S. K. Sanganalmath et al., “Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction,” Circulation, vol. 121, no. 2, pp. 293–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Dawn, A. B. Stein, K. Urbanek et al., “Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3766–3771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kawada, J. Fujita, K. Kinjo et al., “Intracoronary administration of cardiac stem cells improves cardiac function in pigs with old infarction,” Circulation, vol. 114, no. 18, supplement 2, p. II-239, 2006. View at Google Scholar
  23. K. Urbanek, M. Rota, S. Cascapera et al., “Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival,” Circulation Research, vol. 97, no. 7, pp. 663–673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T.-S. Yeh, Y.-H. Dean Fang, C.-H. Lu et al., “Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction,” Biomaterials, vol. 35, no. 1, pp. 174–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Chintalgattu, D. M. Nair, and L. C. Katwa, “Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 3, pp. 277–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Marsano, R. Maidhof, J. Luo et al., “The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction,” Biomaterials, vol. 34, no. 2, pp. 393–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. N. I. Chaudhary, G. J. Roth, F. Hilberg et al., “Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis,” European Respiratory Journal, vol. 29, no. 5, pp. 976–985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Tang, J. Wang, X. Kong et al., “Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway,” Experimental Cell Research, vol. 315, no. 20, pp. 3521–3531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Grunewald, I. Avraham, Y. Dor et al., “VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells,” Cell, vol. 124, no. 1, pp. 175–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Claes, W. Vandevelde, L. Moons, and M. Tjwa, “Another angiogenesis-independent role for VEGF: SDF1-dependent cardiac repair via cardiac stem cells,” Cardiovascular Research, vol. 91, no. 3, pp. 369–370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Guo, W. Jie, Z. Shen et al., “SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling,” International Journal of Molecular Medicine, vol. 34, pp. 112–118, 2014. View at Publisher · View at Google Scholar
  33. X. Liu, B. Duan, Z. Cheng et al., “SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion,” Protein & Cell, vol. 2, no. 10, pp. 845–854, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Iwasaki, M. Koyanagi, H. Kossmann et al., “Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts,” European Heart Journal, vol. 32, no. 5, pp. 627–636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. M. Ellison, D. Torella, S. Dellegrottaglie et al., “Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart,” Journal of the American College of Cardiology, vol. 58, no. 9, pp. 977–986, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-M. Tang, J.-N. Wang, L. Zhang et al., “VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart,” Cardiovascular Research, vol. 91, no. 3, pp. 402–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. D. Abbott, Y. Huang, D. Liu, R. Hickey, D. S. Krause, and F. J. Giordano, “Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury,” Circulation, vol. 110, no. 21, pp. 3300–3305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Huang, J. Qian, J. Ma et al., “Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction,” Stem Cell Research and Therapy, vol. 5, no. 1, article 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Nikami, J. Nedergaard, and J. M. Fredriksson, “Norepinephrine but not hypoxia stimulates HIF-1α gene expression in brown adipocytes,” Biochemical and Biophysical Research Communications, vol. 337, no. 1, pp. 121–126, 2005. View at Publisher · View at Google Scholar · View at Scopus